Search - tctmd.com

Displaying 201 - 220 of 2378

Sort: Relevancy | Date

Presentation TCT 2024

Post-Thrombotic Iliac Vein Obstruction: Tips and Tricks

Presenter: Saher Sabri

October 30, 2024

Presentation TCT 2024

Non-thrombotic Iliac Vein Compression: How to Get Results and Avoid Complications

Presenter: Hady Lichaa

October 30, 2024

Presentation TCT 2024

Intervention for IVC Obstruction

Presenter: Erin Murphy

October 30, 2024

Presentation TCT 2024

Iliac Vein Obstruction: Diagnostics and Deciding Who to Treat

Presenter: S. Jay Mathews

October 30, 2024

Presentation TCT 2024

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Sanjum Sethi

October 30, 2024

Presentation TCT 2024

The Catheter Space is Getting Crowded! How Do We Sort Through All the New Devices?

Presenter: Jay Giri

October 30, 2024

Presentation TCT 2024

Toughest CLTI Case of the Year

Presenter: Arthur Lee

October 30, 2024

Presentation TCT 2024

Toughest AortoIliac Case of the Year

Presenter: Yonatan Bitton-Faiwiszewski

October 30, 2024

Presentation TCT 2024

AI is the Future of PE Care

Presenter: Dan Shilo

October 30, 2024

Presentation TCT 2024

Case Presentation: High/High Intermediate Risk PE

Presenter: Jun Li

October 30, 2024

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Akhilesh Sista

October 30, 2024

Presentation TCT 2024

Other Disease Entities Treated With PE Technologies: Vegetations And Masses

Presenter: Sanjum Sethi

October 30, 2024

Presentation TCT 2024

CDT, Medium and Large Bore Devices: How Do We Choose?

Presenter: Tai Kobayashi

October 30, 2024

Presentation TCT 2024

AI Based Image Analysis Algorithms: Implementation and Impact

Presenter: Andrew Sharp

October 30, 2024

Presentation TCT 2024

Advances In Intervention For Chronic PE

Presenter: Vikas Aggarwal

October 30, 2024

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Jay Giri

October 30, 2024

Presentation TCT 2024

How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

Presenter: Daniel Burkhoff

October 30, 2024

Presentation TCT 2024

TCT 309: Endovascular Interventions in Patients Hospitalized With Stroke: Trends, Outcomes and Predictors

Presenter: Abdul Rasheed Bahar

October 29, 2024

Presentation TCT 2024

TCT 312: Clinical Predictors of Mortality in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy: A Nonlinear, Internally Validated Model

Presenter: Henriette Mészáros

October 29, 2024

Presentation TCT 2024

Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial

Presenter: Wissam Jaber

October 29, 2024

Advertisement

Post-Thrombotic Iliac Vein Obstruction: Tips and Tricks

Non-thrombotic Iliac Vein Compression: How to Get Results and Avoid Complications

Intervention for IVC Obstruction

Iliac Vein Obstruction: Diagnostics and Deciding Who to Treat

PE is a R Heart Disease: How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

The Catheter Space is Getting Crowded! How Do We Sort Through All the New Devices?

Toughest CLTI Case of the Year

Toughest AortoIliac Case of the Year

AI is the Future of PE Care

Case Presentation: High/High Intermediate Risk PE

Clinical Trial Update in 2024

Other Disease Entities Treated With PE Technologies: Vegetations And Masses

CDT, Medium and Large Bore Devices: How Do We Choose?

AI Based Image Analysis Algorithms: Implementation and Impact

Advances In Intervention For Chronic PE

Clinical Trial Update in 2024

How Can We Integrate Hemodynamics Into Current Risk Stratification Paradigms?

TCT 309: Endovascular Interventions in Patients Hospitalized With Stroke: Trends, Outcomes and Predictors

TCT 312: Clinical Predictors of Mortality in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy: A Nonlinear, Internally Validated Model

Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content